Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
GEVA - As of  06/18/13, 06:57:58 PM:   82 Insider Transactions.

Sector: Healthcare    Industry: Biotechnology
Prev Close:$42.28  Avg Vol(3m): 91,620  P/E: 0.00  EPS: -2.08

Email this page to a friend.    Institutional Transactions for GEVA

                Buy: Blue    Sell: Red
Non-meaningful transactions (gifts, grants, etc.) are automatically filtered out for quicker actions.
Buy(P) /
Sell(S)		 P/S date Filed Date Company Symbol Insider Relationship Share Amt. Unit Price Total Proceeds Shares Owned Return(1m) Details
S 2013-06-12 2013-06-13 17:28:54 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 40,352 $40.48 $1,633,450.00 1,031 view
S 2013-06-11 2013-06-13 17:28:54 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 29,648 $40.89 $1,212,310.00 1,031 view
S 2013-04-08 2013-04-09 16:21:51 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 21,695 $49.49 $1,073,690.00 1,031 1.84% view
S 2013-04-05 2013-04-09 16:21:51 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 9,910 $50.11 $496,590.00 1,031 5.05% view
S 2013-04-01 2013-04-03 10:21:48 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) 619 $54.92 $33,995.50 0 14.22% view
S 2013-04-01 2013-04-03 10:21:48 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) 3,797 $54.21 $205,835.00 619 13.10% view
S 2013-03-01 2013-03-06 08:00:04 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP, Product Development) 1,713 $51.35 $87,962.50 0 -4.81% view
S 2013-03-01 2013-03-06 08:00:04 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP, Product Development) 2,704 $50.39 $136,255.00 1,713 -6.81% view
S 2013-02-21 2013-02-22 17:06:34 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 45,392 $49.02 $2,225,120.00 1,031 -8.28% view
S 2013-02-20 2013-02-22 17:06:34 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 5,954 $49.60 $295,318.00 1,031 -6.03% view
S 2013-02-20 2013-02-22 17:06:34 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 18,654 $49.49 $923,186.00 6,985 -6.26% view
S 2013-02-01 2013-02-05 17:36:36 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP, Product Development) 2,660 $48.02 $127,733.00 0 -7.66% view
S 2013-02-01 2013-02-05 17:36:36 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP, Product Development) 1,757 $47.33 $83,158.80 2,660 -9.23% view
S 2013-01-18 2013-01-23 17:06:08 SYNAGEVA BIOPHARMA CORP GEVA Quinn Anthony (SVP, Chief Medical Officer) 9,447 $50.08 $473,106.00 15,035 -2.66% view
S 2013-01-17 2013-01-18 17:00:50 SYNAGEVA BIOPHARMA CORP GEVA Quinn Anthony (SVP, Chief Medical Officer) 200 $50.00 $10,000.00 15,035 -2.82% view
S 2013-01-16 2013-01-18 17:00:50 SYNAGEVA BIOPHARMA CORP GEVA Quinn Anthony (SVP, Chief Medical Officer) 5,353 $50.07 $268,025.00 15,035 -2.68% view
S 2013-01-16 2013-01-18 16:50:56 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 9,927 $49.12 $487,614.00 0 -4.66% view
P 2013-01-09 2013-01-15 17:48:45 SYNAGEVA BIOPHARMA CORP GEVA TISCH THOMAS J director 21,039 $47.53 $999,984.00 373,560 1.45% view
P 2013-01-04 2013-01-08 17:42:31 SYNAGEVA BIOPHARMA CORP GEVA BAKER FELIX director 10% owner 20,099 $47.53 $955,306.00 176,920 1.66% view
P 2013-01-04 2013-01-08 17:42:31 SYNAGEVA BIOPHARMA CORP GEVA BAKER FELIX director 10% owner 839,621 $47.53 $3.99072E7 6,782,220 1.66% view
P 2013-01-04 2013-01-08 17:41:11 SYNAGEVA BIOPHARMA CORP GEVA 14159, L.P. various various various various various various d 20,099 $47.53 $955,306.00 176,920 1.66% view
P 2013-01-04 2013-01-08 17:41:11 SYNAGEVA BIOPHARMA CORP GEVA 14159, L.P. various various various various various various d 839,621 $47.53 $3.99072E7 6,782,220 1.66% view
S 2013-01-02 2013-01-04 16:30:59 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP, Product Development) 4,417 $47.52 $209,896.00 0 -0.99% view
S 2012-12-19 2012-12-21 15:45:40 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Vice President, Finance) 1,605 $46.07 $73,942.40 0 -10.55% view
S 2012-12-19 2012-12-21 15:45:40 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Vice President, Finance) 2,395 $45.83 $109,763.00 1,605 -11.13% view
S 2012-12-17 2012-12-17 19:15:45 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 1,600 $47.53 $76,048.00 1,031 -4.92% view
S 2012-12-17 2012-12-17 19:15:45 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 23,715 $47.03 $1,115,320.00 2,631 -6.04% view
S 2012-12-17 2012-12-17 19:15:45 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 7,004 $45.97 $321,974.00 26,346 -8.48% view
S 2012-12-14 2012-12-17 19:15:45 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 13,281 $45.30 $601,629.00 1,031 -8.23% view
S 2012-12-13 2012-12-17 19:15:45 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 2,701 $47.07 $127,136.00 1,031 -3.93% view
S 2012-12-13 2012-12-17 19:15:45 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 3,300 $45.87 $151,371.00 3,732 -6.65% view
S 2012-12-13 2012-12-17 19:15:45 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 8,399 $45.12 $378,963.00 7,032 -8.42% view
S 2012-12-05 2012-12-06 17:06:13 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 12,000 $48.10 $577,255.00 1,031 1.19% view
S 2012-12-04 2012-12-06 17:06:13 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 23,000 $49.34 $1,134,850.00 1,031 3.67% view
S 2012-12-03 2012-12-04 17:21:04 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 30,000 $49.42 $1,482,490.00 1,031 3.82% view
S 2012-11-30 2012-12-04 17:21:04 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 5,000 $48.87 $244,326.00 1,031 5.25% view
S 2012-10-17 2012-10-19 17:10:49 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Vice President, Finance) 2,000 $49.67 $99,340.00 0 2.54% view
S 2012-10-17 2012-10-19 17:10:49 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Vice President, Finance) 2,000 $49.64 $99,280.00 2,000 2.48% view
S 2012-10-16 2012-10-18 17:40:55 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 900 $51.17 $46,053.00 0 5.39% view
S 2012-10-16 2012-10-18 17:40:55 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 1,900 $50.58 $96,102.00 900 4.29% view
S 2012-10-16 2012-10-18 17:40:55 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 7,127 $49.88 $355,495.00 2,800 2.95% view
S 2012-09-04 2012-09-06 17:00:46 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Vice President, Finance) 300 $49.52 $14,856.00 0 -16.24% view
S 2012-09-04 2012-09-06 17:00:46 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Vice President, Finance) 700 $48.92 $34,244.00 300 -17.66% view
S 2012-09-04 2012-09-05 17:30:57 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 54,813 $49.36 $2,705,370.00 1,031 -16.62% view
S 2012-08-31 2012-09-05 17:30:57 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 15,187 $49.88 $757,518.00 1,031 -7.12% view
S 2012-07-18 2012-07-20 17:45:47 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 6,618 $48.82 $323,091.00 0 -1.95% view
P 2012-07-13 2012-07-13 18:59:58 SYNAGEVA BIOPHARMA CORP GEVA 14159, L.P. various various various various various various d 21,082 $41.20 $868,578.00 156,821 18.93% view
P 2012-07-13 2012-07-13 18:59:58 SYNAGEVA BIOPHARMA CORP GEVA 14159, L.P. various various various various various various d 864,918 $41.20 $3.56346E7 5,942,590 18.93% view
P 2012-07-13 2012-07-13 18:48:26 SYNAGEVA BIOPHARMA CORP GEVA BAKER FELIX director 10% owner 21,082 $41.20 $868,578.00 156,821 18.93% view
P 2012-07-13 2012-07-13 18:48:26 SYNAGEVA BIOPHARMA CORP GEVA BAKER FELIX director 10% owner 864,918 $41.20 $3.56346E7 5,942,590 18.93% view
P 2012-07-12 2012-07-13 16:20:11 SYNAGEVA BIOPHARMA CORP GEVA TISCH THOMAS J director 36,500 $41.20 $1,503,800.00 352,521 19.54% view
P 2012-07-12 2012-07-13 16:20:11 SYNAGEVA BIOPHARMA CORP GEVA TISCH THOMAS J director 36,500 $41.20 $1,503,800.00 378,435 19.54% view
S 2012-07-12 2012-07-13 14:33:51 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 29,200 $46.75 $1,365,100.00 186,357 -5.35% view
S 2012-06-27 2012-06-28 18:01:49 SYNAGEVA BIOPHARMA CORP GEVA AKKARAJU SRINIVAS other 313,451 $39.70 $1.2444E7 1,026,830 -26.42% view
S 2012-06-26 2012-06-28 18:01:49 SYNAGEVA BIOPHARMA CORP GEVA AKKARAJU SRINIVAS other 28,827 $40.16 $1,157,660.00 1,340,280 -24.43% view
S 2012-06-25 2012-06-27 17:25:49 SYNAGEVA BIOPHARMA CORP GEVA Quinn Anthony (SVP, Chief Medical Officer) 26,000 $40.65 $1,056,870.00 20,035 -20.40% view
S 2012-06-04 2012-06-05 17:10:48 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 20,866 $34.69 $723,785.00 1,031 -19.35% view
S 2012-06-01 2012-06-05 17:10:48 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 9,234 $35.96 $332,087.00 1,031 -12.78% view
S 2012-06-01 2012-06-05 17:10:48 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 19,900 $35.70 $710,446.00 10,265 -13.61% view
S 2012-06-01 2012-06-05 17:10:38 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Vice President, Finance) 200 $36.44 $7,287.00 0 -11.32% view
S 2012-06-01 2012-06-05 17:10:38 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Vice President, Finance) 800 $35.56 $28,446.00 200 -14.07% view
S 2012-05-16 2012-05-18 16:45:59 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 11,572 $38.82 $449,225.00 0 2.06% view
S 2012-05-16 2012-05-18 16:45:59 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 28,137 $38.16 $1,073,710.00 11,572 0.37% view
S 2012-04-23 2012-04-23 16:05:02 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 3,000 $40.10 $120,300.00 44,750 3.29% view
S 2012-04-20 2012-04-23 16:05:02 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 10,000 $39.66 $396,600.00 47,750 2.17% view
S 2012-03-23 2012-03-27 17:31:04 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 50,000 $33.53 $1,676,410.00 1,031 -14.80% view
S 2012-02-29 2012-03-09 08:39:18 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 1,512 $39.19 $59,255.30 57,750 9.67% view
S 2012-02-29 2012-03-09 08:39:18 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 3,488 $39.19 $136,695.00 167,912 9.67% view
S 2012-02-22 2012-03-09 08:39:18 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 2,118 $38.90 $82,390.20 171,400 12.72% view
S 2012-02-21 2012-03-09 08:37:38 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 942 $38.90 $36,643.80 173,518 11.54% view
S 2012-02-17 2012-03-09 08:37:38 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 9,190 $38.50 $353,815.00 174,460 13.77% view
S 2012-02-16 2012-03-09 08:37:38 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 15,750 $38.01 $598,658.00 183,650 12.65% view
S 2012-02-15 2012-03-09 08:37:38 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 24,481 $37.34 $914,121.00 199,400 11.44% view
S 2012-02-13 2012-03-09 08:37:38 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 61,262 $36.20 $2,217,680.00 235,557 9.78% view
S 2012-02-10 2012-03-09 08:37:38 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 582 $35.70 $20,777.40 296,819 7.14% view
S 2012-02-07 2012-03-09 08:37:38 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 884 $35.50 $31,382.00 297,401 6.11% view
S 2012-02-06 2012-03-09 08:37:38 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 5,716 $35.62 $203,604.00 298,285 5.87% view
S 2012-02-02 2012-03-09 08:37:38 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 100 $35.50 $3,550.00 304,001 0.45% view
S 2012-02-01 2012-03-09 08:37:38 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 9,975 $35.50 $354,112.00 304,101 0.48% view
S 2012-02-27 2012-02-29 09:28:30 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris officer (Vice President, Finance) 4,500 $36.88 $165,960.00 0 0.68% view
P 2012-01-10 2012-01-17 15:45:32 SYNAGEVA BIOPHARMA CORP GEVA TISCH THOMAS J 10% owner 120,000 $25.18 $3,021,600.00 341,935 41.86% view
P 2012-01-10 2012-01-11 10:45:58 SYNAGEVA BIOPHARMA CORP GEVA TISCH THOMAS J 10% owner 1,200,000 $25.18 $3.0216E7 341,935 41.86% view
* An * after P or S in the Buy/Sell column means the transaction was filed by the insider as open market, but it was marked as private transaction by insidercow's proprietary method
Enter Another Stock Symbol: